Literature DB >> 23664560

Characterization of xanthatin: anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo.

Wei D Li1, Yu Wu, Lei Zhang, Ling G Yan, Fang Z Yin, Jun S Ruan, Zhi P Chen, Guang M Yang, Cui P Yan, Ding Zhao, Yin Lu, Bao C Cai.   

Abstract

Anti-cancer investigations on Xanthatin mainly focus on in vitro experiments. We herein reported the anti-tumor effects of Xanthatin both in vitro and in vivo. MTS assay results showed that Xanthatin had a remarkable anti-proliferative effect on B16-F10 cells. Moreover, the expression of β-catenin was up-regulated both in vitro and in vivo. Animal studies further revealed that Xanthatin killed the tumor cells around the blood vessels which contributes to reduce microvascular density extremely. All these results indicate that Xanthatin inhibited murine melanoma B16-F10 cell proliferation possibly associated with activation of Wnt/β-catenin pathway and its activity against melanoma tumor might also be relevant to inhibition of angiogenesis.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Melanoma; Wnt/β-catenin signaling; Xanthatin

Mesh:

Substances:

Year:  2013        PMID: 23664560     DOI: 10.1016/j.phymed.2013.03.006

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells.

Authors:  Yao Yu; Jing Yu; Chong Gang Pei; Yun Yan Li; Ping Tu; Gui Ping Gao; Yi Shao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.

Authors:  Li Tao; Fangtian Fan; Yuping Liu; Weidong Li; Lei Zhang; Junshan Ruan; Cunsi Shen; Xiaobo Sheng; Zhijie Zhu; Aiyun Wang; Wenxing Chen; Shile Huang; Yin Lu
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

3.  Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.

Authors:  Yu-Yang Ma; Ze-Min Di; Qing Cao; Wen-Shuang Xu; Si-Xing Bi; Ji-Shuang Yu; Yu-Jun Shen; Yong-Qiang Yu; Yu-Xian Shen; Li-Jie Feng
Journal:  Acta Pharmacol Sin       Date:  2019-11-07       Impact factor: 6.150

4.  Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle.

Authors:  Jie Yang; Yongyun Li; Chunyan Zong; Qianqian Zhang; Shengfang Ge; Lei Ma; Jiayan Fan; Jianming Zhang; Renbing Jia
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

5.  Xanthatin Induces Leishmanicidal Activity by Affecting Carbon Metabolism in Amastigotes.

Authors:  Ziba Akbari; KeyKavoos Seyfouri; Roghayeh Mirzazadeh; Elena Jamali; Zahra Zamani; Mohammad Arjmand
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 6.  Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action.

Authors:  Abdul Waheed Khan; Mariya Farooq; Muhammad Haseeb; Sangdun Choi
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

7.  (-)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin.

Authors:  Shuso Takeda; Masayo Hirao-Suzuki; Mitsuru Shindo; Hironori Aramaki
Journal:  Curr Issues Mol Biol       Date:  2022-08-25       Impact factor: 2.976

8.  Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.

Authors:  Mei Shen; Xue-Zhi Zhou; Lei Ye; Qing Yuan; Ce Shi; Pei-Wen Zhu; Nan Jiang; Ming-Yang Ma; Qi-Chen Yang; Yi Shao
Journal:  Int J Mol Med       Date:  2018-04-30       Impact factor: 4.101

Review 9.  Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization.

Authors:  Zachary Barry; Bomina Park; Timothy W Corson
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.